Chronic Myeloproliferative Disease
Cancer
Chronic Myeloproliferative Disease is treated with 3 medications in our database, including RYONCIL, JAKAFI, Inrebic. 1 of these has manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Mesoblast, Incyte, Bristol Myers Squibb. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Chronic Myeloproliferative Disease treatment below.
What help exists for Chronic Myeloproliferative Disease
3
drugs indexed
3
with copay cards
3
with patient assistance
0
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Chronic Myeloproliferative Disease
3 totalJAKAFI
ruxolitinib
ππInrebic
Fedratinib Hydrochloride
ππRYONCIL
remestemcel-l-rknd Β· Mesoblast
ππ
π = copay card Β· π = patient assistance program
Prior authorization patterns for Chronic Myeloproliferative Disease drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |